About this trial
This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth.
Eligibility criteria
Qualifiers
Children between the ages of 4-17 years
(a) a principal diagnosis of an anxiety or mood disorder per DSM-5 criteria, OR (b) parent report of clinically impairing irritability, emotional dysregulation, and/or disruptive behavior in youth
Child and parent must be able to complete consent documents, assessments, and participate in treatment in English without a translator
At least one parent must be available and willing to participant in both phases.
Disqualifiers
Gross neurological, sensory, or motor impairment
History of seizure disorder, psychosis, or organic brain syndrome
Conditions requiring acute intervention, e.g., active suicidality
Non-English speaking child or parent
Trial design
Treatments tested in this trial
- Cognitive Behavioral Therapy
Treatment groups
Sponsors and collaborators
Florida State University
Lead sponsor
National Cancer Institute (NCI)
Collaborator